Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors.

Authors

Sajeve Samuel Thomas

Sajeve Samuel Thomas

Orlando Health Cancer Institute, Orlando, FL

Sajeve Samuel Thomas , Brian Pico , Brian S. Henick , Rom Leidner , Yazan Samhouri , James Isaacs , Jared Weiss , Michael E. Hurwitz , Jaspreet Singh Grewal , Jason J. Luke , Shrikanta Chattopadhyay , Yun Wang , Marlyane Motta , Jim Murray , Debora Barton , Dawn Pinchasik , Gavin MacBeath , Justin C Moser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Clinical Trial Registration Number

NCT05973487; NCT05812027

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 2542)

DOI

10.1200/JCO.2024.42.16_suppl.2542

Abstract #

2542

Poster Bd #

21

Abstract Disclosures